Gene Symbol | TANK |
Entrez ID | 10010 |
Uniprot ID | Q92844 |
Description | TRAF family member associated NFKB activator |
Chromosomal Location | chr2: 161,136,908-161,236,221 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0006508 |
proteolysis |
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
IEA |
BP |
GO:0006974 |
cellular response to DNA damage stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
IMP |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007249 |
I-kappaB kinase/NF-kappaB signaling |
The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
IBA |
BP |
GO:0035666 |
TRIF-dependent toll-like receptor signaling pathway |
Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response. |
TAS |
BP |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling |
Any process that stops, prevents, or reduces the frequency, rate or extent of -kappaB kinase/NF-kappaB signaling. |
IMP |
BP |
GO:0071347 |
cellular response to interleukin-1 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
IMP |
BP |
GO:0071356 |
cellular response to tumor necrosis factor |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
IMP |
BP |
GO:0071479 |
cellular response to ionizing radiation |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays. |
IMP |
BP |
GO:1903003 |
positive regulation of protein deubiquitination |
Any process that activates or increases the frequency, rate or extent of protein deubiquitination. |
IMP |
BP |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity |
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity. |
IMP |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
TAS |
CC |
GO:0043234 |
protein complex |
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
IDA |
MF |
GO:0004843 |
thiol-dependent ubiquitin-specific protease activity |
Catalysis of the thiol-dependent hydrolysis of a peptide bond formed by the C-terminal glycine of ubiquitin and another protein. |
IMP |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0031625 |
ubiquitin protein ligase binding |
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
IPI |
MF |
GO:0035800 |
deubiquitinase activator activity |
Increases the activity of deubiquitinase, an enzyme that catalyzes the hydrolysis of various forms of polymeric ubiquitin sequences. |
IMP |
MF |
GO:0046872 |
metal ion binding |
Interacting selectively and non-covalently with any metal ion. |
IEA |
Domain ID | Description |
---|---|
IPR024581 |
Tbk1/Ikki binding domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04621 |
NOD-like receptor signaling pathway |
KEGG |
hsa04622 |
RIG-I-like receptor signaling pathway |
KEGG |
WP2637 |
Structural Pathway of Interleukin 1 (IL-1) |
WikiPathways |
WP3865 |
RIG-I-like Receptor Signaling |
WikiPathways |
WP231 |
TNF alpha Signaling Pathway |
WikiPathways |
h_stressPathway |
TNF/Stress Related Signaling |
BioCarta |
h_tnfr2Pathway |
TNFR2 Signaling Pathway |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C1458155 |
Mammary Neoplasms |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
appendix |
glandular cells |
bronchus |
respiratory epithelial cells |
colon |
glandular cells |
gallbladder |
glandular cells |
hippocampus |
neuronal cells |
lung |
macrophages |
parathyroid gland |
glandular cells |
small intestine |
glandular cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
17148555 |
Wood et al. |
2007 |
Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
TRADD |
8717 |
Q15628 |
0.00 |
IKBKB |
3551 |
O14920 |
0.52 |
APP |
351 |
P05067 |
0.56 |
USP7 |
7874 |
Q93009 |
0.62 |
BIK |
638 |
Q13323 |
0.63 |
CBLB |
868 |
Q13191 |
0.63 |
CD40 |
958 |
P25942 |
0.63 |
COPB1 |
1315 |
P53618 |
0.63 |
FBLN1 |
2192 |
P23142 |
0.63 |
KPNA2 |
3838 |
P52292 |
0.63 |
RACGAP1 |
29127 |
Q9H0H5 |
0.63 |
INPP5K |
51763 |
Q9BT40 |
0.63 |
ZC3H12A |
80149 |
Q5D1E8 |
0.63 |
MARCH5 |
54708 |
Q9NX47 |
0.65 |
CALM2 |
805 |
P62158 |
0.72 |
CALM3 |
808 |
P62158 |
0.72 |
CLTC |
1213 |
Q00610 |
0.72 |
HNRNPU |
3192 |
Q00839 |
0.72 |
HSPA1A |
3303 |
P0DMV8 |
0.72 |
HSPA1B |
3304 |
P0DMV9 |
0.72 |
HSPA1L |
3305 |
P34931 |
0.72 |
HSPA5 |
3309 |
P11021 |
0.72 |
HSPA8 |
3312 |
P11142 |
0.72 |
HSPA9 |
3313 |
P38646 |
0.72 |
IARS |
3376 |
P41252 |
0.72 |
IRF3 |
3661 |
Q14653 |
0.72 |
KARS |
3735 |
Q15046 |
0.72 |
IPO5 |
3843 |
O00410 |
0.72 |
KRT1 |
3848 |
P04264 |
0.72 |
KRT9 |
3857 |
P35527 |
0.72 |
KRT16 |
3868 |
P08779 |
0.72 |
HNRNPM |
4670 |
P52272 |
0.72 |
NAP1L1 |
4673 |
P55209 |
0.72 |
LARS |
51520 |
Q9P2J5 |
0.72 |
TUBA3C; TUBA3D |
113457 |
Q13748 |
0.72 |
CEP63 |
80254 |
Q96MT8 |
0.73 |
TRAF1 |
7185 |
Q13077 |
0.74 |
APBA3 |
9546 |
O96018 |
0.75 |
IRF7 |
3665 |
Q92985 |
0.76 |
BIRC2 |
329 |
Q13490 |
0.82 |
PLK1 |
5347 |
P53350 |
0.86 |
TANK |
10010 |
Q92844 |
0.88 |
TRAF3 |
7187 |
Q13114 |
0.90 |
IKBKG |
8517 |
Q9Y6K9 |
0.90 |
TRAF2 |
7186 |
Q12933 |
0.97 |
MAP3K1 |
4214 |
Q13233 |
0.00 |
MAP4K4 |
9448 |
O95819 |
0.00 |
HLA-C |
3107 |
P30508 |
0.49 |
CEP128 |
145508 |
Q6ZU80 |
0.49 |
RARA |
5914 |
P10276 |
0.56 |
SUMO1 |
7341 |
P63165 |
0.56 |
MAP4K5 |
11183 |
Q9Y4K4 |
0.62 |
HTT |
3064 |
P42858 |
0.63 |
HLA-C |
3107 |
P30499 |
0.63 |
LAMC1 |
3915 |
P11047 |
0.63 |
SMAD3 |
4088 |
P84022 |
0.63 |
SDC4 |
6385 |
P31431 |
0.63 |
TP53BP2 |
7159 |
Q13625 |
0.63 |
ZFP36 |
7538 |
P26651 |
0.63 |
AIMP2 |
7965 |
Q13155 |
0.63 |
BBOX1 |
8424 |
O75936 |
0.63 |
HERC2 |
8924 |
O95714 |
0.63 |
MAP3K14 |
9020 |
Q99558 |
0.63 |
SRSF11 |
9295 |
Q05519 |
0.63 |
TAB2 |
23118 |
Q9NYJ8 |
0.63 |
ATP6V1H |
51606 |
Q9UI12 |
0.63 |
MUL1 |
79594 |
Q969V5 |
0.63 |
SUMO2 |
6613 |
P61956 |
0.68 |
BIRC3 |
330 |
Q13489 |
0.72 |
RARS |
5917 |
P54136 |
0.72 |
ITGB1BP1 |
9270 |
O14713 |
0.72 |
TICAM1 |
148022 |
Q8IUC6 |
0.72 |
CHUK |
1147 |
O15111 |
0.73 |
TRIM37 |
4591 |
O94972 |
0.75 |
IKBKE |
9641 |
Q14164 |
0.90 |
TBK1 |
29110 |
Q9UHD2 |
0.97 |